# Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation)

> **NCT03672383** · NA · COMPLETED · sponsor: **Bayer** · enrollment: 42 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DEVICE:** BAY987534

## Key facts

- **NCT ID:** NCT03672383
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-17
- **Primary completion:** 2018-10-17
- **Final completion:** 2018-10-17
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03672383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03672383, "Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03672383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*